| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,259,821 |
|
|
|
Indirect Value
|
$148,965,006 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$150,224,827 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-05 |
4 |
S |
$62.56 |
$3,483,530 |
D/D |
(55,020) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-05 |
4 |
OE |
$4.50 |
$445,250 |
D/D |
75,020 |
237,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-28 |
4 |
S |
$62.55 |
$2,191,850 |
D/D |
(35,000) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-28 |
4 |
OE |
$5.72 |
$200,158 |
D/D |
35,000 |
217,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-10-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
47,536 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-11-25 |
4 |
S |
$58.00 |
$3,194,000 |
D/D |
(55,000) |
182,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-11-25 |
4 |
OE |
$6.53 |
$359,222 |
D/D |
55,000 |
237,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2003-12-19 |
4 |
OE |
$6.53 |
$19,594 |
D/D |
3,000 |
185,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-05 |
4 |
S |
$56.00 |
$3,035,200 |
D/D |
(54,200) |
190,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-05 |
4 |
OE |
$5.63 |
$398,749 |
D/D |
59,200 |
244,258 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
250 |
47,286 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
250 |
47,036 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-04 |
4 |
OE |
$6.53 |
$78,376 |
D/D |
12,000 |
202,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-05 |
4 |
S |
$58.30 |
$3,790,400 |
D/D |
(65,000) |
202,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-05 |
4 |
OE |
$9.50 |
$617,500 |
D/D |
65,000 |
267,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2004-05-06 |
4 |
OE |
$2.86 |
$82,831 |
D/D |
28,968 |
663,654 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-08-11 |
4 |
S |
$65.52 |
$3,936,875 |
D/D |
(60,000) |
207,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-08-11 |
4 |
OE |
$6.53 |
$908,285 |
D/D |
65,000 |
267,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
OE |
$7.30 |
$1,313,442 |
D/D |
180,000 |
595,550 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,300 |
92,772 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-10-28 |
4 |
S |
$35.00 |
$6,335,590 |
D/D |
(180,000) |
415,550 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-11-29 |
4 |
OE |
$2.86 |
$104,129 |
D/D |
32,632 |
448,182 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
S |
$33.10 |
$5,513,043 |
D/D |
(166,296) |
448,182 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
OE |
$7.30 |
$1,213,445 |
D/D |
166,296 |
614,478 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
S |
$33.12 |
$212,166 |
I/I |
(6,400) |
800 |
|
- |
|
193 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
